Cleared Traditional

K180858 - CALLISTO eye

K180858 is the FDA 510(k) clearance for CALLISTO eye by Carl Zeiss Meditec, AG. It is a Class 2 Ophthalmic device (product code NFJ) cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K180858 · Carl Zeiss Meditec, AG · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2018
Decision
86d
Days
Class 2
Risk

K180858 is an FDA 510(k) clearance for the CALLISTO eye. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Carl Zeiss Meditec, AG (Jena, DE). The FDA issued a Cleared decision on June 27, 2018 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Carl Zeiss Meditec, AG devices

Submission Details

510(k) Number K180858 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2018
Decision Date June 27, 2018
Days to Decision 86 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 110d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

Carl Zeiss Meditec, Inc.
Mandy Ambrecht

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 26
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K180858.
Harmony
K182376 · Topcon Medical Systems, Inc. · Sep 2018
Image Filing Software NAVIS-EX
K181345 · Nidek Co., Ltd. · Jul 2018
Welch Allyn RetinaVue Network REF 901108 PACS Medical Image System
K181016 · Welch Allyn, Inc. · Jul 2018
Ophthalmic Software Platform RX
K173689 · Canon Inc. -Medical Equipment Group · Feb 2018
NIDEK ADVANCED VISION INFORMATION SYSTEM (NAVIS)
K013694 · Nidek, Inc. · Nov 2002